C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.510
+0.110 (3.24%)
At close: Sep 11, 2026, 4:00 PM EDT
3.500
-0.010 (-0.28%)
After-hours: Sep 11, 2026, 7:30 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $431.82 million as of September 11, 2026. Its market cap has increased by 129.82% in one year.
Market Cap
431.82M
Enterprise Value
188.23M
1-Year Change
129.82%
Ranking
Category
Stock Price
$3.51
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $431.82M, a decrease of -44.12%. That is a compound annual growth rate of -9.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 431.82M | 133.28% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 435.63M |
| Relmada Therapeutics | 434.15M |
| Inhibikase Therapeutics | 424.23M |
| Benitec Biopharma | 419.81M |
| Vogenx | 415.58M |
| Atea Pharmaceuticals | 415.46M |
| Editas Medicine | 406.99M |
| Larimar Therapeutics | 401.87M |